Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Sanofi, Regeneron and FDA
Regeneron-Sanofi Drug Wins FDA Approval To Treat COPD
Shares of Regeneron Pharmaceuticals and Sanofi edged higher Friday after their drug to treat chronic obstructive pulmonary disease received approval from the Food and Drug Administration.
Sanofi-Regeneron's Dupixent wins FDA's nod for 'smoker's lung'
The U.S. Food and Drug Administration has approved Sanofi and Regeneron's blockbuster drug Dupixent for patients with a chronic lung disease, commonly known as "smoker's lung", the companies said on Friday.
Regeneron And Sanofi Snag Their $6 Billion-Potential COPD Approval For Dupixent
Regeneron stock XX on XX after the company won FDA approval for Dupixent in chronic obstructive pulmonary disease, or COPD.
12h
Regeneron: Long-Term Defensive Investment
Regeneron's R&D expenses are projected to reach $5 billion, but the business remains highly profitable. Read why I rate REGN ...
2d
Dupixent® (dupilumab) Approved in China as the First-ever Biologic Medicine for Patients with Chronic Obstructive Pulmonary Disease (COPD)
Approval follows EU approval of Dupixent for adults with COPD with raised blood eosinophils, and is based on two landmark Phase 3 trials showing ...
devdiscourse
12h
A Snapshot of Current Health Developments
Bristol Myers gains FDA approval for a new schizophrenia drug. HHS declares a health emergency in Georgia due to Hurricane ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Helene death toll rises
'Days of Our Lives' star dies
Vance’s Pennsylvania rally
Hospitalized for burns
'SNL' launches 50th season
Malibu coast earthquake
Chief adviser subpoenaed
Trump to visit Fayetteville
Rescue mission launched
Earth's orbit new asteroid
NC dam failure ‘imminent’
Faces fine to end Brazil ban
Szarewicz case update
Steward CEO to step down
Ukrainian drones shot down
ISR strikes Lebanon again
On Hezbollah leader's killing
Deposition in AI suit
NY ballot appeal rejected
KY sues Express Scripts
Haney sues Garcia
Congestion fee bid denied
High-end brothel plea
Dow closes at record high
Houthis attack US warships
121st loss of the season
Van Gogh paintings attacked
Diocese reaches settlement
Congressional Gold Medal
UNC digital IDs blocked
Human rabies death in MN
ICE: Convicts roaming free
Feedback